HeartSmartTM: A New Method of Assessing Hydration in Neurosurgical Patients

Abstract

Background: Maintenance of normal fluid homeostasis is challenging in neurosurgical patients. Consequently, we studied hydration assessment in neurosurgical intensive care patients. Methods: Pulmonary artery catheter thermodilution (PACTD) is the conventional method for measuring cardiac index (CI) and mean pulmonary artery occlusion (MPAOP) or wedge pressure (MPWP). We compared values from this technique with those derived from continuous cardiac dynamic monitoring (CCDM)-HeartSmart?, a new, less invasive, software-based technique. Over 4 years, we undertook an audit of 101 paired sets of data from 21 patients with sub-arachnoid hemorrhage who had pulmonary artery flotation catheters inserted as part of their treatment. Measured values of CI and MPWP were obtained retrospectively from patients’ charts and compared with values calculated using CCDM-HeartSmart? software. Results: Using the Bland-Altman method for comparing two measurement techniques, there was good agreement between measured and calculated MPWP (mean of differences –1.81, SD 3.97, SE 0.39, 95% CI –2.59 to 2.04 l/min/m2; two-sided p < 0.0001). The measured and calculated values of CI were also in good agreement (mean of differences 0.36, SD 1.30, SE 0.13, 95% CI 0.109 - 0.619; two-sided p = 0.0055, 95% limits of agreement –2.1 to 2.91 l/min/m2). This indicates that, when estimating CI and MPWP in critically ill neurosurgical patients, CCDM-HeartSmart? provides values close to those generated using PACTD. Conclusions: The CCDM-HeartSmart? could prove invaluable for optimizing response to fluid replacement and for guiding cardiovascular support in neurosurgical patients. This new, simple technology may help to facilitate routine adoption of perioperative optimization of blood flow using early goal-directed therapy.

Share and Cite:

K. James Warring-Davies and J. Martin Bland, "HeartSmartTM: A New Method of Assessing Hydration in Neurosurgical Patients," Surgical Science, Vol. 3 No. 11, 2012, pp. 546-553. doi: 10.4236/ss.2012.311108.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] L. D. Mishra and R. L. Gairola, “Perioperative Fluid Management in Neurosurgical Patients,” Journal of Anaesthesiology Clinical Pharmacology, Vol. 20, No. 2, 2004, pp. 113-119.
[2] V. Papantchev, S. Hristov, D. Todorova, E. Naydenov, A. Paloff, D. Nikolov, A. Tschirkov and W. Ovtscharoff, “Some Variations of the Circle of Willis, Important for Cerebral Protection in Aortic Surgery—A Study in Eastern Europeans,” European Journal Cardio-Thoracic Surgery, Vol. 31, No. 6, 2007, pp. 982-989. doi:10.1016/j.ejcts.2007.03.020
[3] J. C. Berridge, K. Warring-Davies, J. M. Bland and A. C. Quinn, “A New, Minimally Invasive Technique for Measuring Cardiac Index: Clinical Comparison of Continuous Cardiac Dynamic Monitoring and Pulmonary Artery Catheter Methods,” Anaesthesia, Vol. 64, No. 9, 2009, pp. 961-967. doi:10.1111/j.1365-2044.2009.05943.x
[4] J. J. Pandit, “Graphical Presentation of Data in Non-Invasive Algorithms for Cardiac Output Estimation,” Anaesthesia, Vol. 65, No. 3, 2010, pp. 310-311. doi:10.1111/j.1365-2044.2010.06256_1.x
[5] G. B. Drummond, N. Soni and M. G. Palazzo, “Prediction and Theory in Cardiac Output Estimates,” Anaesthesia, Vol. 65, No. 7, 2010, pp. 751-753. doi:10.1111/j.1365-2044.2010.06394.x
[6] K. Warring-Davies and M. Bland, “HeartSmart for Routine Optimization of Blood Flow and Facilitation of Early Goal-Directed Therapy,” Journal of Open Access Journal of Clinical Trials, Vol. 2, 2010, pp. 115-123. doi:10.2147/OAJCT.S9843
[7] K. Warring-Davies and M. Bland, “Validating HeartSmart against the Cardiopulmonary Bypass Machine,” Surgical Science, Vol. 3, No. 1, 2012, pp. 21-27. doi:10.4236/ss.2012.31004
[8] J. M. Bland and D. G. Altman, “Agreement between Methods of Measurement with Multiple Observations per Individual,” J Biopharm Stat, Vol. 17, No. 4, 2007, pp. 571-582. doi:10.1080/10543400701329422
[9] J. M. Bland and D. G. Altman, “Measuring Agreement in Method Comparison Studies,” Statistical Methods in Medical Research, Vol. 8, No. 2, 1999, pp. 135-160. doi:10.1191/096228099673819272
[10] D. A. McDonald, “Blood Flow in Arteries,” 2nd Edition, Edward Arnold, London, 1960.
[11] D. Fabbroni and A. Quinn, “A Retrospective Evaluation of the Heartsmart (TM) Continuous Cardiac Dynamic Monitor in Neurosurgical Patients,” Journal of Neurosurgical Anesthesiology, Vol. 17, No. 3, 2005, p. 156. doi:10.1097/01.ana.0000174366.25361.4c
[12] L. A. Critchley and J. A. Critchley, “A Meta-Analysis of Studies Using Bias and Precision Statistics to Compare Cardiac Output Measurement Techniques,” Journal of Clinical Monitoring and Computing, Vol. 15, No. 2, 1999, pp. 85-91. doi:10.1023/A:1009982611386
[13] C. Davey and S. Wilson, “Market Review: Haemodynamic Monitoring Systems,” 2010. http://nhscep.useconnect.co.uk/CEPProducts/Catalogue.aspx
[14] S. Harvey, D. A. Harrison, M. Singer, J. Ashcroft, C. M. Jones, D. Elbourne, W. Brampton, D. Williams, D. Young and K. Rowan, “PAC-Man Study Collaboration, Assessment of the Clinical Effectiveness of Pulmonary Artery Catheters in Management of Patients in Intensive Care (PAC-Man): A Randomised Controlled Trial,” Lancet, Vol. 366, No. 9484, 2005, pp. 472-477. doi:10.1016/S0140-6736(05)67061-4
[15] M. G. Sriram, J. R. Rodriguez, K. A. Johnson, G. Kantor, J. R. Svirbely and J. W. Smith, “Implementing Medical Algorithms for Use in Cardiology,” 2009. http://en.scientificcommons.org/42631289
[16] K. J. Warring-Davies and J. M. Bland, “HeartSmart: The Art of Making Haemodynamic Monitoring Simple.” http://www.apccardiovascular.co.uk/pdf/heartsmart_leaflet.pdf.
[17] R. D. Brandstetter and B. Gitler, “Thoughts on the Swan-Ganz Catheter,” Chest, Vol. 89, No. 1, 1986, pp. 5-6. doi:10.1378/chest.89.1.5
[18] A. Rhodes and R. M. Grounds, “New Technologies for Measuring Cardiac Output: The Future?” Current Opinion in Critical Care, Vol. 11, No. 3, 2005, pp. 224-226. doi:10.1097/01.ccx.0000158093.41924.9d
[19] M. Hadian and M. R. Pinsky, “Evidence-Based Review of the Use of the Pulmonary Artery Catheter: Impact Data and Complications,” Critical Care, Vol. 10, No. S3, 2006, p. S8. doi:10.1186/cc4834
[20] C. W. Stetz, R. G. Miller, G. E. Kelly and T. A. Raffin, “Reliability of the Thermodilution Method in the Determination of Cardiac Output in Clinical Practice,” American Review Of Respiratory Disease, Vol. 126, No. 6, 1982, pp. 1001-1004.
[21] A. Schubert, “Cardiovascular Therapy of Neurosurgical Patients,” Best Practice & Research Clinical Anaesthesiology, Vol. 21, No. 4, 2007, pp. 483-496. doi:10.1016/j.bpa.2007.06.003
[22] S. M. Tibby and I. A. Murdoch, “Monitoring Cardiac Function in Intensive Care,” Archives of Disease in Childhood, Vol. 88, No. 1, 2003, pp. 46-52. doi:10.1136/adc.88.1.46
[23] E. Rivers, B. Nguyen, S. Havstad, J. Ressler, A. Muzzin, B. Knoblich, E. Peterson and M. Tomlanovich, “Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock,” The New England Journal of Medicine, Vol. 345, No. 19, 2001, pp. 1368-1377. doi:10.1056/NEJMoa010307
[24] R. Pearse, D. Dawson, J. Fawcett, A. Rhodes, R. M. Grounds and E. D. Bennett, “Early Goal-Directed Therapy after Major Surgery Reduces Complications and Duration of Hospital Stay. A Randomised, Controlled Trial [ISRCTN38797445],” Critical Care, Vol. 9, No. 6, 2005, pp. R687-R693. doi:10.1186/cc3887
[25] D. T. Huang, G. Clermont, T. T. Dremsizov and D. C. Angus, “Implementation of Early Goal-Directed Therapy for Severe Sepsis and Septic Shock: A Decision Analysis,” Critical Care Medicine, Vol. 35, No. 9, 2007, pp. 2090-2100. doi:10.1097/01.CCM.0000281636.82971.92
[26] T. Mutoh, K. Kazumata, T. Ishikawa and S. Terasaka, “Performance of Bedside Transpulmonary Thermodilution Monitoring for Go l-Directed Hemodynamic Management after Subarachnoid Hemorrhage,” Stroke, Vol. 40, No. 7, 2009, pp. 2368-2374.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.